Keywords: AstraZeneca, Brilique, Brilinta, Cost-effective, Scotland, Denmark, QUALY

AstraZeneca achieves three significant milestones for blood thinner Brilique

Article | 10 May 2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday announced three items of news regarding its potential blockbuster blood thinner Brilique/Brilinta ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

AstraZeneca

Go to company listing

Related Drugs

Brilique

Brilinta

Go to drug listing